Supporting a role of leptin in cancer pathogenesis are reports that DNA polymorphisms in the leptin and ObR genes are associated with increased risk and progression of breast [42], prostate [43], and oral cancer [44]. This evidence concerns the gene LEP and lip and oral cavity carcinoma.